Dextromethorphan Distribution Act of 2007

S 1378/HR 970, Dextromethorphan Distribution Act of 2007, restrictions on distribution of bulk Dextromethorphan.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program. H.R.1424, the Emergency Economic Stabilization Act of 2008, as related to fiscal sustainablity of healthcare services. H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program. H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program. H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals. H.R.6353/S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies. H.R.6357, PRO(TECH)T Act of 2008, as related to pharmacy involvement in health information technology. H.R. 6898, the Health-e Information Technology Act of 2008 as related to pharmacy involvement in health information technology H.R. 7110, the Job Creation and Unemployment Relief Act of 2008, as related to increased funding for state Medicaid programs. S.484, the Enhancing Drug Safety and Innovation Act, all provisions related to the safety of prescription medicines. S. 1276, the Methamphetamine Production Prevention Act as related to recordkeeping requirements for pharmacies. S.1693, Wired for Health Care Quality Act, as related to health information technology. S.1827, Pharmacists Access and Recognition in Medicare (PhARM) Act, as related to provider participation in the Medicare program. S.1915, Electronic Prescribing Drug Act, as related to the regulation of electronic prescribing of pharmaceuticals. S.1951, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. S.1954, Pharmacy Access Improvement (PhAIm) Act, as related to access standards to pharmacies. S.2013/H.R.390, Patient and Pharmacy Protection Act, as related to prescription requirements in the Medicaid program. S.2071, Combat Methamphetamine Enhancement Act, as related to the distribution of legal substances used in the production of methamphetamine. S.2274, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan. S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to electronic health care in the Medicare program. S.3101/H.R.6331, Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement in the Medicaid and Medicare programs and electronic health care. Various issues related to the disposal of prescription drugs and drug Take Back programs, no specific legislation

Client expense: $320,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office

FDA reform proposals; Pseudoephedrine H.R. 970 DXM Distribution Act S. 1378 DXM Distribution Act S. 2274 Dextromethorphan Abuse Reduction Act Monograph System Reform Proposal S. 2274 DXM Abuse Reduction Act

Client expense: $756,650 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Agency (NSA), Natl Security Council (NSC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

H.R. 970/S. 1378 To amend the Federal Food, Drug and Cosmetic Act with respect to the distribution of the drug Dextromethorphan, and for other purposes; (Sections pertaining to DXM.)

Client expense: $1,591,930 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 4703, S 2467, HR 4991 - Vaccine Shortage preparedness Act of 2008 S 2464, HR 4992, HR 4704 - A bill to amend title XVIII of the Social Security Act to provide for coverage of federally recommended vaccines under Medicare Part B S 2465 - Vaccines for Children Access Act of 2008 HR 5839 - Safeguarding America's Pharmaceuticals Act of 2008 S 3408 - Comparative Effectiveness Research Act of 2008 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 S 2467 - Vaccine shortage preparedness Act of 2008 S 3678 - /PL 109-417 All pandemic and all-hazards act - Section 317 program issues HR 970 and S 1378 - Dextromethorphan Distribution Act of 2007 S 103 - Combat Meth Act of 2005 HR 2207 - Agricultural Disaster Assistance and Western States Emergency - Unfinished business Appropriations Act of 2007 HR 1908 and S 1710 Patent Reform Act of 2007 HR 1 - Implementing the 9/11 Commission recommendations Act of 2007 HR 3162 - Children's Health and Medicare Protection Act of 2007 S 1505 - Affordable Biologics for Consumers Act S 1695 - Biologics Price Competition and Innovation Act of 2007 HR 1956 - Patent Protection and Innovative Biologic Medicines Act of 2007 HR 1038, S623 - Access to Life-Saving Medicine Act HR 4083 - Non-prescription Drug Modernization Act of 2007 HR 1308 - Legal Immigrant Children's Health Improvement Act of 2007 HR 5629 - Pathway for Biosimilars Act Comparative Effectiveness Research Public Health Service Act Drug Importation Gene Therapy Direct to Consumer Advertising Drug Safety Legislation Global Hypertension

Client expense: $1,377,211 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Agency for International Development (USAID)

See addendum. H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program. H.R.1108, Family Smoking Prevention and Tobacco Control Act, as related to the regulation of the sale of tobacco products. H.R.1424, the Emergency Economic Stabilization Act of 2008, as related to fiscal sustainablity for healthcare services. H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program. H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. H.R.4008, Credit and Debit Card Receipt Clarification Act of 2007, as related to fair credit card practices. H.R.5491, Emilys Act, as related to the certification of pharmacy technicians. H.R.5546, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program. H.R.5658, Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals. H.R.6353/S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies. H.R.6357, PRO(TECH)T Act of 2008, as related to pharmacy involvement in health information technology. H.R. 6491/S.3434, the Organized Retail Crime Act of 2008, as related to the prosecution of organized theft. H.R. 6713, the E-Fencing Enforcement Act of 2008, as related to the prosecution of organized theft. H.R. 6831/S.3666, the Copper Theft Prevention Act of 2008 as related to theft and interstate fencing of stolen copper. H.R. 6898, the Health-e Information Technology Act of 2008 as related to pharmacy involvement in health information technology H.R. 7110, the Job Creation and Unemployment Relief Act of 2008, as related to increased funding for state Medicaid programs. S.484, the Enhancing Drug Safety and Innovation Act, all provisions related to the safety of prescription medicines. S. 1276, the Methamphetamine Production Prevention Act as related to recordkeeping requirements for pharmacies. S.1693, Wired for Health Care Quality Act, as related to health information technology. S.1827, Pharmacists Access and Recognition in Medicare (PhARM) Act, as related to provider participation in the Medicare program. S.1915, Electronic Prescribing Drug Act, as related to the regulation of electronic prescribing of pharmaceuticals. S.1951, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. S.1954, Pharmacy Access Improvement (PhAIm) Act, as related to access standards to pharmacies. S.2013/H.R.390, Patient and Pharmacy Protection Act, as related to prescription requirements in the Medicaid program. S.2071, Combat Methamphetamine Enhancement Act, as related to the distribution of legal substances used in the production of methamphetamine. S.2274, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan. S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to electronic health care in the Medicare program. S.2978, Credit and Debit Card Receipt Clarification Act of 2008, as related to fair credit card practices S.3001, National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. S.3086, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. S.3101/H.R.6331, Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement in the Medicaid and Medicare programs and electronic health care.

Client expense: $300,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), President of the U.S., SENATE

Dextromethorphan Abuse, Methamphetamine S. 2237, S. 2274, S. 1378, HR 970, S. 1276

Client expense: $116,217 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

HR 6337, Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 - Title III, Privacy and Security Provisions - would require a patient's written consent before using their health information for certain purposes. HR 6331Medicare Patients and Providers Improvement Act - AMP - Provisions relating to retail pharmacy and Medicaid drug reimbursement (became public law 7/15/08) HR 5839, Safeguarding America's Pharmaceuticals Act - E-Pedigree mandates, enhanced wholesaler licensing, national uniform standards HR 970 and S. 2274, Dextromethorphan Distribution Act of 2007- prohibits sale of DXM products to persons under 18 years of age. HR 6898, Health-e Information Technology Act of 2008, Title IV, Privacy and Security Provisions - allows pharmacies to use protected health information for treatment, payment and healthcare operations.

Client expense: $1,600,130 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE

S 1378/HR 970, Dextromethorphan Distribution Act of 2007, restrictions on distribution of bulk Dextromethorphan.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues Related to compounding pharmacies, in particular to FDA action to ban estriol or further restrict access to estriol or other drus used in the compounding process. Specifically working on H. Con. Res. 342 and S. Con Res. 88, as well as FDA Reauthorization and drug-specific bills (the DXM access bill: H.R. 970 and S. 1378.

Client expense: Not reported · Firm income: Not reported

Issues Related to compounding pharmacies, in particular to FDA action to ban estriol or further restrict access to estriol or other drus used in the compounding process. Specifically working on H. Con. Res. 342 and S. Con Res. 88, as well as FDA Reauthorization and drug-specific bills (the DXM access bill: H.R. 970 and S. 1378.

Client expense: Not reported · Firm income: Not reported

Issues Related to compounding pharmacies, in particular to FDA action to ban estriol or further restrict access to estriol or other drus used in the compounding process. Specifically working on H. Con. Res. 342 and S. Con Res. 88, as well as FDA Reauthorization and drug-specific bills (the DXM access bill: H.R. 970 and S. 1378.

Client expense: Not reported · Firm income: Not reported

Issues Related to compounding pharmacies, in particular to FDA action to ban estriol or further restrict access to estriol or other drus used in the compounding process. Specifically working on H. Con. Res. 342 and S. Con Res. 88, as well as FDA Reauthorization and drug-specific bills (the DXM access bill: H.R. 970 and S. 1378.

Client expense: Not reported · Firm income: Not reported

Issues Related to compounding pharmacies, in particular to FDA action to ban estriol or further restrict access to estriol or other drus used in the compounding process. Specifically working on H. Con. Res. 342 and S. Con Res. 88, as well as FDA Reauthorization and drug-specific bills (the DXM access bill: H.R. 970 and S. 1378.

Client expense: Not reported · Firm income: Not reported

Issues Related to compounding pharmacies, in particular to FDA action to ban estriol or further restrict access to estriol or other drus used in the compounding process. Specifically working on H. Con. Res. 342 and S. Con Res. 88, as well as FDA Reauthorization and drug-specific bills (the DXM access bill: H.R. 970 and S. 1378.

Client expense: Not reported · Firm income: Not reported

Issues Related to compounding pharmacies, in particular to FDA action to ban estriol or further restrict access to estriol or other drus used in the compounding process. Specifically working on H. Con. Res. 342 and S. Con Res. 88, as well as FDA Reauthorization and drug-specific bills (the DXM access bill: H.R. 970 and S. 1378.

Client expense: Not reported · Firm income: Not reported

Issues Related to compounding pharmacies, in particular to FDA action to ban estriol or further restrict access to estriol or other drus used in the compounding process. Specifically working on H. Con. Res. 342 and S. Con Res. 88, as well as FDA Reauthorization and drug-specific bills (the DXM access bill: H.R. 970 and S. 1378.

Client expense: Not reported · Firm income: Not reported

Issues Related to compounding pharmacies, in particular to FDA action to ban estriol or further restrict access to estriol or other drus used in the compounding process. Specifically working on H. Con. Res. 342 and S. Con Res. 88, as well as FDA Reauthorization and drug-specific bills (the DXM access bill: H.R. 970 and S. 1378.

Client expense: Not reported · Firm income: Not reported

FDA reform proposals; Pseudoephedrine H.R. 970 DXM Distribution Act S. 1378 DXM Distribution Act S. 2274 Dextromethorpha Abuse Reduction Act Monograph System Reform Proposal S. 2274 DXM Abuse Reduction Act

Client expense: $801,472 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Agency (NSA), Natl Security Council (NSC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Dextromethorphan Abuse S. 2237, S. 2274, S. 1378, H.R. 970

Client expense: $110,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Dextromethorphan Abuse, Methamphetamine S. 2237, S. 2274, S. 1378, H.R. 970, S. 1276

Client expense: $150,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

S.1951 and HR 3700, Fair Medicaid Drug Payment Act of 2007, AMP - Provisions relating to retail pharmacy and Medicaid drug reimbursement. S. 3101, Medicare Improvement for Patients and Providers Act, AMP - Provisions relating to retail pharmach and Medicaid drug reimbrusement HR 6331Medicare Patients and Providers Improvement Act, - AMP - Provisions relating to retail pharmacy and Medicaid drug reimbursement HR 5839, Safeguarding America's Pharmaceuticals Act -- E-Pedigree mandates, enhanced wholesaler licensing, national uniform standards HR 970 and S. 2274, Dextromethorphan Distribution Act of 2007, -- prohibits sale of DXM products to persons under 18 years of age

Client expense: $1,708,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

HR 4703, S 2467, HR 4991 - Vaccine Shortage preparedness Act of 2008 S 2464, HR 4992, HR 4704 - A bill to amend title XVIII of the Social Security Act to provide for coverage of federally recommended vaccines under Medicare Part B S 2465 - Vaccines for Children Access Act of 2008 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 S 2467 - Vaccine shortage preparedness Act of 2008 S 3678 - /PL 109-417 All pandemic and all-hazards act - Section 317 program issues HR 970 and S 1378 - Dextromethorphan Distribution Act of 2007 S 103 Combat Meth Act of 2005 HR 2207 - Agricultural Disaster Assistance and Western States Emergency - Unfinished business Appropriations Act of 2007 HR 1908 and S 1710 Patent Reform Act of 2007 HR 1 - Implementing the 9/11 Commission recommendations Act of 2007 HR 3162 - Children's Health and Medicare Protection Act of 2007 S 1505 Affordable Biologics for Consumers Act S 1695 Biologics Price Competition and Innovation Act of 2007 HR 1956 - Patent Protection and Innovative Biologic Medicines Act of 2007 HR 1038, S623 - Access to Life-Saving Medicine Act HR 4083 - Non-prescription Drug Modernization Act of 2007 HR 1308 - Legal Immigrant Children's Health Improvement Act of 2007 HR 5629 - Pathway for Biosimilars Act Comparative Effectiveness Research Public Health Service Act Drug Importation Gene Therapy Direct to Consumer Advertising Drug Safety Legislation Global Hypertension

Client expense: $1,345,921 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Agency for International Development (USAID)

See addendum. H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program. H.R.1038/S.623, Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.1108, Family Smoking Prevention and Tobacco Control Act, as related to the regulation of the sale of tobacco products. H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program. H.R.3140, Saving Our Community Pharmacies Act, as related to Medicaid provider reimbursement. H.R.3193, Access to Community Pharmacy Preservation Act, as related to Medicaid provider reimbursement. H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. H.R.4008, Credit and Debit Card Receipt Clarification Act of 2007, as related to fair credit card practices. H.R.5491, Emilys Act, as related to the certification of pharmacy technicians. H.R.5546, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program. H.R.5629, Pathway for Biosimilars Act, as related to the availability of generic pharmaceuticals. H.R.5658, Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals. H.R.6252, Medicare DMEPOS Competitive Acquisition Reform Act of 2008, as related to provider participation in the Medicare competitive bidding program. H.R.6331, the Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement, electronic health care, and Medicare programs. H.R.6353, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies. H.R.6357, PRO(TECH)T Act of 2008, as related to health information technology. S.484, the Enhancing Drug Safety and Innovation Act, all provisions related to the safety of prescription medicines. S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies. S.1693, Wired for Health Care Quality Act, as related to health information technology. S.1695, the Biologics Price Competition and Innovation Act, as related to the approval of generic biopharmaceuticals. S.1827, Pharmacists Access and Recognition in Medicare (PhARM) Act, as related to provider participation in the Medicare program. S.1915, Electronic Prescribing Drug Act, as related to the regulation of electronic prescribing of pharmaceuticals. S.1951, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. S.1954, Pharmacy Access Improvement (PhAIm) Act, as related to access standards to pharmacies. S.2013/H.R.390, Patient and Pharmacy Protection Act, as related to prescription requirements in the Medicaid program. S.2071, Combat Methamphetamine Enhancement Act, as related to the distributio of legal substances used in the production of methamphetamine. S.2274, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan. S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to electronic health care in the Medicare program. S.2978, Credit and Debit Card Receipt Clarification Act of 2008, as related to fair credit card practices S.3001, National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. S.3086, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. S.3101, Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement and electronic health care.

Client expense: $420,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), President of the U.S., SENATE

S 1378/HR 970, Dextromethorphan Distribution Act of 2007, restrictions on distribution of bulk Dextromethorphan.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4703, S. 2467, H.R. 4991 -- Vaccine Shortage Preparedness Act of 2008 S. 2467, H.R. 4703, H.R. 4991 -- A bill to amend the Social Security Act, the Federal Food, Drug and Cosmetic Act, and the Public Health Service Act H.R. 970 and S. 1378 -- Dextromethorphan Distribution Act S. 3678 -- Pandemic All Hazards Preparedness Act (Biodefense) S. 103 Combat Meth Act H.R. 1908 and S. 1710 -- Patient Reform Act H.R. 3162 -- Children's Health and Medicare Protection Act S. 1505 -- Affordable Biologics for Consumers Act S. 1695 -- Biolgoics Price Competition and Innovation Act Comparative effectiveness research Drug importation Direct to consumer advertising Drug safety legislation FDA funding Issues related to the use of thimerisol in vaccines

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FDA reform proposals; Pseudoephedrine S. 1276 Methamphetamine Production Preventation Act of 2007 H.R. 970 DXM Distribution Act S. 1378 DXM Distribution Act DXM Abuse Monograph System Reform Proposal S. 2274 DXM Abuse Reduction Act H.R. 4083 Non-Prescription Drug modernization Act of 2007

Client expense: $697,236 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Agency (NSA), Natl Security Council (NSC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

S.1951 and HR 3700, Fair Medicaid Drug Payment Act of 2007, AMP - Provisions relating to retail pharmacy and Medicaid drug reimbursement. HR 970, Dextromethorphan Distribution Act of 2007, DXM - bill restricts the sale/distribution of drugs containing dextromethorphan.

Client expense: $1,360,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

HR4703, S2467, HR4991 - Vaccine Shortage Preparedness Act of 2008 S2464, HR4992, HR4704 - A bill to amend title XVIII of the Social Security Act to provide for coverage of federally recommended vaccines under Medicare part B S. 2465, HR 4702, HR 4990 A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. S. 2467, HR 4703, HR 4991 A bill to amend the Social Security Act, the Federal Food, Drug and Cosmetic Act, and the Public Health Service Act to ensure a sufficient supply of vaccines, and for other purposes. HR4705 - Vaccines for the Uninsured Adult Act of 2008 S3678 H.R. 970 and S. 1378 - Dextromethorphan Distribution Act of 2007 S.3678 Pandemic All Hazards Preparedness Act (Biodefense) S.103 Combat Meth Act of 2005 H.R. 2207 - Agricultural Disaster Assistance and Western States Emergency Unfinished Business Appropriations Act of 2007 H.R. 1908 and S. 1710 - Patent Reform Act of 2007 H.R 1 - Implementing the 9/11 Commission Recommendations Act of 2007 H.R. 3162 - Children's Health and Medicare Protection Act of 2007 S. 1505 Affordable Biologics for Consumers Act S. 1695 Biologics Price Competition and Innovation Act of 2007 H.R. 1956 Patient Protection and Innovative Biologic Medicines Act of 2007 H.R. 1038 Access to Life-Saving Medicine Act S.623 Access to Life-Saving Medicine Act H.R. 4083 Non-Prescription Drug Modernization Act of 2007 S. 2311 Non-Prescription Drug Modernization Act of 2007 Comparative Effectiveness Research Public Health Service Act Drug Importation Gene Therapy Direct to Consumer Advertising Drug Safety Legislation Global Hypertension Best Pharmaceuticals for Children's Act Pediatric Research Equity Act Pharmaceuticals in water FDA Funding Reagan/Udall Foundation Counter Detailing

Client expense: $1,250,450 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Agency for International Development (USAID)

See addendum. 1.S.242/H.R.380, the Pharmaceutical Market Access and Drug Safety Act of 2007, as related to provisions governing the importation of prescription drugs. 2.S.251, the Pharmaceutical Market Access Act of 2007, all provisions governing the importation of prescription drugs. 3.S. 484, the Enhancing Drug Safety and Innovation Act of 2007, all provisions related to the safety of prescription medicines. 4.S. 604, the Military Health Care Protection Act, as related to provider participation in the Department of Defense TRICARE program. 5.S. 980, Online Pharmacy Consumer Protection Act of 2007, as related to the regulation of online pharmacies. 6.S. 1200, Indian Health Care Improvement Act Amendments of 2007, all provisions related to reducing fraud and abuse in the Medicare program. 7.S. 1276/H.R.2747, the Methamphetamine Production Prevention Act of 2007, as related to the distribution of legal substances used in the production of methamphetamine. 8.S. 1693, the Wired for Health Care Quality Act of 2007, as related to improving health information technology. 9.S. 1695, the Biologics Price Competition and Innovation Act of 2007, as related to the approval of generic biopharmaceuticals. 10.S. 1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 as related to provider participation in the Medicare program. 11.S.1915, Electronic Prescription Drug Act of 2007, as related to the regulation of electronic prescribing of pharmaceuticals 12.S.1951/H.R.3700, Fair Medicaid Drug Payment Act of 2007, as related to Medicaid provider reimbursement. 13.S.1954, Pharmacy Access Improvement (PhAIm) Act of 2007, as related to access standards to pharmacies. 14.S.2013/H.R.3090, Patient and Pharmacy Protection Act of 2007, as related to prescription requirements in the Medicaid program. 15.S.2071, Combat Methamphetamine Enhancement Act of 2007, as related to the distribution of legal substances used in the production of methamphetamine. 16.S.2274, Dextromethorphan Abuse Reduction Act of 2007, as related to steps to prevent the abuse of dextromethorphan. 17.S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to the regulation of electronic prescribing of pharmaceuticals. 18.H.R.976, Small Business Tax Relief Act of 2007, all provisions associated with work-related tax credits. 19.H.R. 970, the Dextromethorphan Distribution Act of 2007, as related to steps to prevent the abuse of dextromethorphan. 20.H.R. 971/S.855, the Community Pharmacy Fairness Act of 2007, as related to provider negotiations in the Medicare program. 21.H.R.1038/S.623, Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. 22.H.R. 1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007, as related to provider reimbursement in the Medicare program 23.H.R.1585/S.1548, National Defense Authorization Act for Fiscal Year 2008, as related to retail pharmacy participation in the Department of Defense TRICARE program. 24.H.R.1845, the Medicare Durable Medical Equipment Access Act of 2007, as related to provider inclusion in the Medicare Part B program. 25.H.R.1902, the Protecting Consumer Access to Generic Drugs Act of 2007, as related to the availability of generic pharmaceuticals. 26.H.R.2716, the Reducing Fraudulent and Imitation Drugs Act of 2007, as related to the safety of prescription drugs. 27.H.R. 2900, the Food and Drug Administration Amendments of 2007, all provisions related to prescription drug information and safety. 28.H.R.3109, the Dental Health Promotion Act of 2007, all provisions related to payment for health services. 29.H.R.3140, Saving Our Community Pharmacies Act of 2007, as related to Medicaid provider reimbursement. 30.H.R.3162, Children's Health and Medicare Protection Act of 2007, provisions related to health insurance in the Medicare program. 31.H.R.3193, Access to Community Pharmacy Preservation Act of 2007, as related to Medicaid provider reimbursement. 32.H.R.3580, Food and Drug Administration Amendments Act of 2007, all provisions related to prescription drug information and safety. 33.H.R.3610, Food and Drug Import Safety Act of 2007, provisions related to the safety of prescription drugs. 34.H.R.5268/S.2620, Temporary Increase of Medicaid FMAP, all provisions related to payments in the Medicaid program. 35.H.R.5480/S.2662, Medicare Funding Warning Response Act of 2008, all provisions related to provider access and payments in the Medicare program. 36.H.R.5491, Emilys Act, as related to the certification of pharmacy technicians. 37.H.R.5546, Credit Card Fair Fee Act of 2008, as related to fees associated with credit card purchase. 38.H.R.5613, Protecting the Medicaid Safety Net Act of 2008, all provisions related to provider participation in the Medicaid program. 39.H.R.5629, Pathway for Biosimilars Act, as related to the availability of generic pharmaceuticals. 40.H.Con.Res.312/S.Con.Res.70, Concurrent Resolution on the Budget for Fiscal Year 2009, all provisions related to healthcare providers and prescription drugs.

Client expense: $370,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Natl Drug Control Policy (NDCP), Office of Personnel Management (OPM), President of the U.S., SENATE

Dextromethorphan Abuse S. 2237, S. 2274, S. 1378, H.R. 970

Client expense: $110,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 4703, S. 2467, HR 4991 -- Vaccine Shortage Preparedness Act of 2008 S 2467, HR 4703, HR 4991 -- A bill to amend the Social Security Act, the Federal Food, Drug and Cosmetic Act, and the Public Health Service Act HR 970 and S 1378 -- Dextromethorphan Distribution Act of 2007 S 3678 -- Pandemic All Hazards Preparedness Act (Biodefense) S 103 Combat Meth Act of 2005 HR 1908 -- and S 1710 -- Patent Reform Act of 2007 HR 3162 -- Children's Health and Medicare Protection Act of 2007 S 1505 -- Affordable Biologics for Consumers Act S 1695 Biologics Price Competition and Innovation Act of 2007 Comparative effectiveness research Drug importation Direct to consumer advertising Drug safety legislation FDA funding Issues related to the use of thimerisol in vaccines

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4703, S. 2467, HR 4991 -- Vaccine Shortage Preparedness Act of 2008 S 2467, HR 4703, HR 4991 -- A bill to amend the Social Security Act, the Federal Food, Drug and Cosmetic Act, and the Public Health Service Act HR 970 and S 1378 -- Dextromethorphan Distribution Act of 2007 S 3678 -- Pandemic All Hazards Preparedness Act (Biodefense) S 103 Combat Meth Act of 2005 HR 1908 -- and S 1710 -- Patent Reform Act of 2007 HR 3162 -- Children's Health and Medicare Protection Act of 2007 S 1505 -- Affordable Biologics for Consumers Act S 1695 Biologics Price Competition and Innovation Act of 2007 Comparative effectiveness research Drug importation Direct to consumer advertising Drug safety legislation FDA funding Issues related to the use of thimerisol in vaccines

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 1378/HR 970, Dextromethorphan Distribution Act of 2007, restrictions on distribution of bulk Dextromethorphan.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.2274, S.1378, H.R.970; Seeking increased restrictions on sale of Dextromethorphan, including prohibition of internet sale of bulk Dextromethorphan and under age 18 restrictions.

Client expense: Not reported · Firm income: Not reported

S.2274, S.1378, H.R.970; Seeking increased restrictions on sale of Dextromethorphan, including prohibition of internet sale of bulk Dextromethorphan and under age 18 restrictions.

Client expense: Not reported · Firm income: Not reported

S. 1378 and HR 970 - Dextromethorphan Distribution Act of 2007 - Restrictions on distribution of bulk Dextromethorphan.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Delays in HIPPA required NPI registery Docket No. 2007N-0356 Comments and Statement Submitted on Behind the Counter Availability of Certain Drugs RE: Docket No. CMS-1385-FC. 42 CFR Parts.160. Medicare Program: Amendment if the E-Prescribing Exemption for Computer-Generated Facsimiles Docket No. 2007P-0074 Joint Meeting of the Nonprescription Drugs Advisory Committee and Pediatric Advisory Committee -Cough and Cold Medications use in Children Statements Submitted on the FDA Nonprescription Drugs Advisory Committee and the Endodrinologic and Metabolic Drugs Advisory Committee Over-the-Counter Use of Mevacor (lovastatin) Voluntary Restricted Distribution of 40mg Methadone to Hospitals Statements Submitted to Senate Judiciary Committee on "Electronic Prescribing of Controlled Substances: Addressing Health Care and Law Enforcement Proirities" Docket No. DEA 298 Combat Methamphetamine Epidemic Act 2005 Self-Certification S1276 Methamphetamine Production Prevention Act of 2007 HR 2747 Methamphetamine Production Prevention Act of 2007 HR 3580 Food and Drug Administration Amendments Act of 2007 HR 2900 Food and Drug Administration Amendments Act of 2007 S 1378 Dextromethorphan Distribution Act of 2007 HR 970 Dextromethorphan Distribution Act of 2007 S 1695 Biologics Price Competition and Innovation Act of 2007

Client expense: $367,997 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, UNDETERMINED

S. 1951 and H.R. 3700 - Average Manufacturer Price: provisions relating to retail pharmacy and Medicaid drug reimbursement H.R. 970 - Dextromethorphan Distribution Act of 2007

Client expense: $800,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, UNDETERMINED

H.R. 970 and S. 1378 - Dextromethorphan Distribution Act of 2007 S.3678 Pandemic All Hazards Preparedness Act (Biodefense) S.103 Combat Meth Act of 2005 H.R. 2206 - Suplemental Appropriations

Client expense: $3,460,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Agency for International Development (USAID)

* HR 3700 / S 1951 - provisions related to retail pharmacy and Medicaid drug reimbursement. HR 970 - Dextromethorphan Distribution Act of 2007. HR 3647 - Tamper-resistant prescription pads delay. HR 970 - Dextromethorphan Distribution Act of 2007. HR 3647 - Tamper-resistant prescription pads delay.

Client expense: $13,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 970, S 1378, S 2237, S 2274 -- Medicine Abuse

Client expense: $244,322 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Proposed restrictions/scheduling of bulk Dextromethorphan - H.R. 970 Dextromethorphan Abuse Reduction Act - S. 2274 Crime Control & Prevention Act of 2007 - S. 2237

Client expense: Not reported · Firm income: $40,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

HR.788/S.468, Food & Drug Administration Safety Act of 2007; HR.970/S.1378, Dextromethorphan Distribution Act of 2007; HR.1952, National Health Information Incentive Act of 2007; S.1082/HR.2900, Prescription Drug User Fee, FDA Act of 2007; S.1753, The Healthy Workforce Act of 2007

Client expense: $1,282,429 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Energy, Dept of, Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Council (NSC), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

S. 1276 Methamphetamine Production Prevention Act of 2007 H.R. 970 DXM Distribution Act S.1378 DXM Distribution Act FDA reform proposals; Pseudoephedrine;

Client expense: $1,820,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office